ArticleScientific reports2022

Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model.

Jun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.